Changing the Culture of the FDA Act

Senate Bill 604 - Changing the Culture of the FDA Act: Overview, Status, and Impact

Hozzl · 2024-02-16T21:08:00Z

Explore the details of Senate Bill 604 Changing the Culture of the FDA Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

2/16/2024, 9:08 PM

Congressional Summary of S 604

Changing the Culture of the FDA Act

This bill requires the Food and Drug Administration to amend its mission statement to state that it is responsible for protecting the public health by considering the danger of addiction and overdose death when approving and regulating prescription opioid medications. (Opioid medications are drugs with effects similar to opium, such as certain pain medications.)

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill S 604

Bill S 604 is currently in the status of Bill Introduced since March 1, 2023. Bill S 604 was introduced during Congress 118 and was introduced to the Senate on March 1, 2023. Bill S 604's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of March 1, 2023